Prostat Kanseri Evrelemesi

Kaynakça

Karaarslan E. Prostat tümörünü görüntülemede ve evrelemede TRUS, gövde ve endorektal anten ile elde edilen sonuçların biopsi ve radikal prostatektomi ile karşılaştırılması. İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi ABD, Radyoloji Uzmanlık Tezi, 1996.

Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, et al. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol 2016; 69: 41-9. [CrossRef]

Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, et al. Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 2014; 39: 1443-8. [CrossRef]

Buyyounouski MK, Cloyke PL, Mc Kenney JK, Sartor O, Sandler MK, Amin MB, et al. Prostate Cancer –Major Changes in the American Joint Committee Eighth Edition Cancer Staging Manual. CA Cancer J Clin 2017; 67: 245-53. [CrossRef]

Soylu FN, Eggener S, Oto A. Local staging of prostate cancer with MRI. Diagn Interv Radiol 2012; 18: 365-73.

Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. European Society of Urogenital Radiology. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746-57. [CrossRef]

Engelbrecht MR, Jagger GJ, Laheij RJ ,Verbeek AL, van Lier HJ, Barentz JO, et al. Local staging of prostate cancer using magnetic resonance imaging: a meta analysis. Eur Radiol 2002; 12: 2294-302. [CrossRef]

Heijmink SW, Fütterer JJ, Hambrock T, Takahashi S, Scheenen TW, Huisman HJ, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 2007; 244: 184-95. [CrossRef]

Sala E, Akın O, Moskowitz CS, Eisenberg HF, Kuroiwa K, Ishill NM, et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology 2006; 238: 929-37. [CrossRef]

Soylu FN, Peng Y, Jiang Y, Wang S, Schmid-Tannwald C, Sethi I, et al. Seminal Vesicle Invasion in Prostate Cancer: Evaluation by Using Multiparametric Endorectal MR Imaging. Radiology 2013; 267: 797-806. [CrossRef]

Vallini V, Ortori S, Boraschi P, Manassero F, Gabelloni M1, Faggioni L, et al. Staging of pelvic lymph nodes in patients with prostate cancer: Usefulness of multiple b value SE-EPI diffusion-weighted imaging on a 3.0 T MR system. Eur J Radiol Open 2015; 3: 16-21. [CrossRef]

Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol 2013; 64: 953-60. [CrossRef]

Park SY, Oh YT, Jung DC, Cho NH, Choi YD, Rha KH. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI. AJR Am J Roentgenol 2015; 205: 328-34. [CrossRef]

Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G, et al. Diagnostic efficacy of (68) gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol 2016; 195: 1436-43. [CrossRef]

Shen G, Deng H, Hu S, Jia Z. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis. Skeletal Radiol 2014; 43: 1503-13. [CrossRef]

Conde-Moreno AJ, Herrando-Parreño G, Muelas-Soria R, Ferrer-Rebolleda J, Broseta-Torres R, Cozar-Santiago MP, et al. Whole-body diffusion-weighted magnetic resonance imaging (WBDW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer. Clin Transl Oncol 2017; 19: 553. [CrossRef]

Knorr K, Eiber M, Maurer T, Wester HJ, Scheidhauer K. PET-CT and PET-MRI of the prostate: From (18) F-FDG to (68)Ga-PSMA. Radiologe 2017; 57: 631-36. [CrossRef]

Kaynak Göster